CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection

Journal of Immunology

Volumn 180, Issue 8, 2008, Pages 5582-5592

  Dunham, Richard M ^a,b,c   Cervasi, Barbara ^a   Brenchley, Jason M ^d   Albrecht, Helmut ^e   Weintrob, Amy ^e   Sumpter, Beth ^b,c   Engram, Jessica ^a   Gordon, Shari ^a,b,c   Klatt, Nichole R ^a,b,c   Frank, Ian ^a   Sodora, Donald L ^f   Douek, Daniel C ^d   Paiardini, Mirko ^a   Silvestri, Guido ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CERCOCEBUS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; ANIMAL; CD4 LYMPHOCYTE COUNT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONKEY DISEASE; PHYSIOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

ADULT; ANIMALS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CERCOCEBUS ATYS; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTE SUBSETS;

EID: 45949112196     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.8.5582     Document Type: Article

References (90)

1. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: 123-126.
2. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122.
3. + T cell demographics and dynamics in lymphatic tissues. Annu. Rev. Immunol. 17: 625-656.
4. Mohri, H., S. Bonhoeffer, S. Monard, A. S. Perelson, and D. D. Ho. 1998. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 279: 1223-1227.
5. + T lymphocyte turnover in simian immunodeficiency virus-infected macaques. Proc. Natl. Acad. Sci. USA. 95: 6388-6393.
6. Hellerstein, M., M. B. Hanley, D. Cesar, S. Siler, C. Papageorgopoulos, E. Wieder, D. Schmidt, R. Hoh, R. Neese, D. Macallan, et al. 1999. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med. 5: 83-89.
7. Hellerstein, M. K., R. A. Hoh, M. B. Hanley, D. Cesar, D. Lee, R. A. Neese, and J. M. McCune. 2003. Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J. Clin. Invest. 112: 956-966.
8. Silvestri, G., and M. B. Feinberg. 2003. Turnover of lymphocytes and conceptual paradigms in HIV infection. J. Clin. Invest. 112: 821-824.
9. Hazenberg, M. D., J. W. Stuart, S. A. Otto, J. C. Borleffs, C. A. Boucher, R. J. de Boer, F. Miedema, and D. Hamann. 2000. T-cell division in human immunodeficiency virus (HIV) -l infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95: 249-255.
10. + T cells go out of stock. Nat. Immunol. 1: 285-289.
11. + T-cell depletion in HIV disease. Nature 410: 974-979.
12. + T-cell depletion in HIV infection: are we closer to understanding the cause? Nat. Med. 8: 319-323.
13. Douek, D. C., L. J. Picker, and R. A. Koup. 2003. T cell dynamics in HIV-1 infection. Annu. Rev. Immunol. 21: 265-304.
14. Giorgi, J. V., L. E. Hultin, J. A. McKeating, T. D. Johnson, B. Owens, L. P. Jacobson, R. Shih, J. Lewis, D. J. Wiley, J. P. Phair, et al. 1999. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179: 859-870.
15. Sousa, A. E., J. Carneiro, M. Meier-Schellersheim, Z. Grossman, and R. M. Victorino. 2002. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169: 3400-3406.
16. + T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77: 11708-11717.
17. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200: 749-759.
18. + T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200: 761-770.
19. Ma, A., R. Koka, and P. Burkett. 2006. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24: 657-679.
20. + T cells in vitro. AIDS Res. Hum. Retroviruses 23: 438-450.
21. + regulatory T cells from HIV-infected individuals. Proc. Natl. Acad. Sci. USA. 104: 3390-3395.
22. Baker, C. A., R. Clark, F. Ventura, N. G. Jones, D. Guzman, D. R. Bangsberg, and H. Cao. 2007. Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection. Clin. Exp. Immunol. 147: 533-539.
23. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200: 331-343.
24. Nilsson, J., A. Boasso, P. A. Velilla, R. Zhang, M. Vaccari, G. Franchini, G. M. Shearer, J. Andersson, and C. Chougnet. 2006. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108: 3808-3817.
25. Andersson, J., A. Boasso, J. Nilsson, R. Zhang, N. J. Shire, S. Lindback, G. M. Shearer, and C. A. Chougnet. 2005. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J. Immunol. 174: 3143-3147.
26. Eggena, M. P., B. Barugahare, N. Jones, M. Okello, S. Mutalya, C. Kityo, P. Mugyenyi, and H. Cao. 2005. Depletion of regulatory T cells in HIV infection is associated with immune activation. J. Immunol. 174: 4407-4414.
27. + regulatory T cells to immune status in HIV-infected patients. AIDS 19: 879-886.
28. +regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104: 3249-3256.
29. + regulatory T cells in antiretroviral-naive HIV patients. AIDS 20: 1669-1671.
30. + regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 108: 3072-3078.
31. Sereti, I., and H. C. Lane. 2001. Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies. Clin. Infect. Dis. 32: 1738-1755.
32. von Freeden-Jeffry, U., P. Vieira, L. A. Lucian, T. McNeil, S. E. Burdach, and R. Murray. 1995. Lymphopenia in interleukin (IL) -7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181: 1519-1526.
33. Peschon, J. J., P. J. Morrissey, K. H. Grabstein, F. J. Ramsdell, E. Maraskovsky B. C. Gliniak, L. S. Park, S. F. Ziegler, D. E. Williams, C. B. Ware, et al. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180: 1955-1960.
34. Fry, T. J., and C. L. Mackall. 2001. Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol. 22: 564-571.
35. Fry, T. J., and C. L. Mackall. 2005. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174: 6571-6576.
36. Park, J. H., Q. Yu, B. Erman, J. S. Appelbaum, D. Montoya-Durango, H. L. Grimes, and A. Singer. 2004. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7- dependent T cell survival. Immunity 21: 289-302.
37. Sasson, S. C, J. J. Zaunders, G. Zanetti, E. M. King, K. M. Merlin, D. E. Smith, K. K. Stanley, D. A. Cooper, and A. D. Kelleher. 2006. Increased plasma interleukin-7 level correlates with decreased CD127 and increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. J. Infect. Dis. 193: 505-514.
38. Kaech, S. M., J. T. Tan, E. J. Wherry, B. T. Konieczny, C. D. Surh, and R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4: 1191-1198.
39. Schluns, K. S., W. C. Kieper, S. C. Jameson, and L. Lefrançois. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1: 426-432.
40. Tan, J. T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K. I. Weinberg, and C. D. Surh. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 98: 8732-8737.
41. high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help. J. Immunol. 174: 5926-5930.
42. Lang, K. S., M. Recher, A. A. Navarini, N. L. Harris, M. Lohning, T. Junt, H. C. Probst, H. Hengartner, and R. M. Zinkernagel. 2005. Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur. J. Immunol. 35: 738-745.
43. Mastroianni, C. M., G. Forcina, G. d'Ettorre, M. Lichtner, F. Mengoni, C. D'Agostino, and V. Vullo. 2001. Circulating levels of interleukin-7 in antiretroviral-naive and highly active antiretroviral therapy-treated HIV-infected patients. HIV Clin. Trials 2: 108-112.
44. Llano, A., J. Barretina, A. Gutierrez, J. Blanco, C. Cabrera, B. Clotet, and J. A. Este. 2001. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J. Virol. 75: 10319-10325.
45. Beq, S., J. F. Delfraissy, and J. Theze. 2004. Interleukin-7 (IL-7) : immune function, involvement in the pathogenesis of HIV infection and therapeutic potential. Eur. Cytokine Network 15: 279-289.
46. Napolitano, L. A., R. M. Grant, S. G. Deeks, D. Schmidt, S. C. De Rosa, L. A. Herzenberg, B. G. Herndier, J. Andersson, and J. M. McCune. 2001. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat. Med. 7: 73-79.
47. Carini, C, M. F. McLane, K. H. Mayer, and M. Essex. 1994. Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection. Eur. J. Immunol. 24: 2927-2934.
48. Vingerhoets, J., E. Bisalinkumi, G. Penne, R. Colebunders, E. Bosmans, L. Kestens, and G. Vanham. 1998. Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. Immunol. Lett. 61: 53-61.
49. + T cells in HIV-infected individuals. J. Immunol. 174: 2900-2909.
50. Colle, J. H., J. L. Moreau, A. Fontanet, O. Lambotte, M. Joussemet, J. F. Delfraissy, and J. Theze. 2006. CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients-reversal by highly active anti-retroviral therapy (HAART). Clin. Exp. Immunol. 143: 398-403.
51. + T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Eur. J. Immunol. 36: 336-344.
52. Rethi, B., C. Fluur, A. Atlas, M. Krzyzowska, F. Mowafi, S. Grutzmeier, A. DeMilito, R. Bellocco, K. I. Falk, E. Rajnavolgyi, and F. Chiodi. 2005. Loss of IL-7Rα is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. AIDS 19: 2077-2086.
53. + T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J. Clin. Invest. 115: 2139-2148.
54. + T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. Blood 104: 775-780.
55. Sereti, I., E. Aga, J. Spritzler, A. Landay, S. Pahwa, M. Fischl, D. Asmuth, A. Tenorio, R. Buffet, and M. M. Lederman. 2007. rhIL-7 in HIV-1-infected subjects with CD4 T-cell count >100cells/uL and viral load <50, 000 copies/mL: results from a randomized, placebo-controlled, double-blinded study (ACTG5214). In I4th Conference on Retroviruses and Opportunistic Infections, February 25-28, 2007, Los Angeles, CA.
56. Levy, Y., L. Weiss, J. P. Viard, J. Molina, C. Goujard, F. Boue, S. Delluc, C. Rouzioux, M. Morre, and J. F. Delfraissy. 2007. Repeated r-hIL-7 doses improve T-cell recovery in HIV-1-infected patients enrolled in a phase I/II multicentric study. In 14th Conference on Retroviruses and Opportunistic Infections, February 25-28, 2007, Los Angeles, CA.
57. + Treg cells. J. Exp. Med. 203: 1701-1711.
58. Seddiki, N., B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, et al. 2006. Expression of interleukin (IL) -2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203: 1693-1700.
59. + regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J. Immunol. Methods 319: 41-52.
60. Brenchley, J. M., B. J. Hill, D. R. Ambrozak, D. A. Price, F. J. Guenaga, J. P. Casazza, J. Kuruppu, J. Yazdani, S. A. Migueles, M. Connors, et al. 2004. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J. Virol. 78: 1160-1168.
61. Douek, D. C., M. R. Betts, J. M. Brenchley, B. J. Hill, D. R. Ambrozak, K. L. Ngai, N. J. Karandikar, J. P. Casazza, and R. A. Koup. 2002. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J. Immunol. 168: 3099-3104.
62. + T cells. Nature 417: 95-98.
63. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22: 745-763.
64. Giorgi, J. V., R. H. Lyles, J. L. Matud, T. E. Yamashita, J. W. Mellors, L. E. Hultin, B. D. Jamieson, J. B. Margolick, C. R. Rinaldo, Jr., J. P. Phair, and R. Detels. 2002. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J. Acquir. Immune Defic. Syndr. 29: 346-355.
65. + cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16: 83-92.
66. + T lymphocytes during HIV-1 infection. J. Acquir. Immune Defic. Syndr. 7: 245-253.
67. Rey-Cuille, M. A., J. L. Berthier, M. C. Bomsel-Demontoy, Y. Chaduc, L. Montagnier, A. G. Hovanessian, and L. A. Chakrabarti. 1998. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J. Virol. 72: 3872-3886.
68. Chakrabarti, L. A., S. R. Lewin, L. Zhang, A. Gettie, A. Luckay, L. N. Martin, E. Skulsky, D. D. Ho, C. Cheng-Mayer, and P. A. Marx. 2000. Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J. Virol. 74: 1209-1223.
69. Silvestri, G., D. L. Sodora, R. A. Koup, M. Paiardini, S. P. O'Neil, H. M. McClure, S. I. Staprans, and M. B. Feinberg. 2003. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18: 441-452.
70. Silvestri, G., A. Fedanov, S. Germon, N. Kozyr, W. J. Kaiser, D. A. Garber, H. McClure, M. B. Feinberg, and S. I. Staprans. 2005. Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J. Virol. 79: 4043-4054.
71. + T cell homeostasis during natural, nonpathogenic simian immunodeficiency virus infection of sooty mangabeys: implications for AIDS pathogenesis J. Immunol. 178: 1680-1691.
72. Silvestri, G. 2005. Naturally SIV-infected sooty mangabeys: are we closer to understanding why they do not develop AIDS? J. Med. Primatol. 34: 243-252.
73. + T cells. J. Immunol. 168: 2225-2232.
74. Stevenson, M. 2003. HIV-1 pathogenesis. Nat. Med. 9: 853-860.
75. Forster, R., G. Schweigard, S. Johann, T. Emrich, E. Kremmer, C. Nerl, and M. Lipp. 1997. Abnormal expression of the B-cell homing chemokine receptor BLR1 during the progression of acquired immunodeficiency syndrome. Blood 90: 520-525.
76. De Milito, A. 2004. B lymphocyte dysfunctions in HIV infection. Curr. HIV Res. 2: 11-21.
77. LaBonte, M. L., P. F. McKay, and N. L. Letvin. 2006. Evidence of NK cell dysfunction in SIV-infected rhesus monkeys: impairment of cytokine secretion and NKG2C/C2 expression. Eur. J. Immunol. 36: 2424-2433.
78. Weissman, D., and A. S. Fauci. 1997. Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection. Clinical Microbiol. Rev. 10: 358-367.
79. Gaines, H., M. A. von Sydow, L. V. von Stedingk, G. Biberfeld, B. Bottiger, L. O. Hansson, P. Lundbergh, A. B. Sonnerborg, J. Wasserman, and O. O. Strannegaard. 1990. Immunological changes in primary HIV-1 infection. AIDS 4: 995-999.
80. Roederer, M., J. G. Dubs, M. T. Anderson, P. A. Raju, L. A. Herzenberg, and L. A. Herzenberg. 1995. CD8 naive T cell counts decrease progressively in HIV- infected adults. J. Clin. Invest. 95: 2061-2066.
81. Gougeon, M. L. 2003. Apoptosis as an HIV strategy to escape immune attack. Nat. Rev. Immunol. 3: 392-404.
82. Badley, A. D., A. A. Pilon, A. Landay, and D. H. Lynch. 2000. Mechanisms of HIV-associated lymphocyte apoptosis. Blood 96: 2951-2964.
83. Fluur, C, A. De Milito, T. J. Fry, N. Vivar, L. Eidsmo, A. Atlas, C. Federici, P. Matarrese, M. Logozzi, E. Rajnavolgyi, et al. 2007. Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection. J. Immunol. 178: 5340-5350.
84. Golden-Mason, L., J. R. Burton, Jr., N. Castelblanco, J. Klarquist, S. Benlloch, C. Wang, and H. R. Rosen. 2006. Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 44: 1098-1109.
85. Fry, T. J., and C. L. Mackall. 2002. Interleukin-7: from bench to clinic. Blood 99: 3892-3904.
86. + T cells in vivo. J. Virol. 78: 9740-9749.
87. Beq, S., M. T. Nugeyre, R. Ho Tsong Fang, D. Gautier, R. Legrand, N. Schmitt, J. Estaquier, F. Barre-Sinoussi, B. Hurtrel, R. Cheynier, and N. Israel. 2006. IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy. J. Immunol. 176: 914-922.
88. Fry, T. J., M. Moniuszko, S. Creekmore, S. J. Donohue, D. C. Douek, S. Giardina, T. T. Hecht, B. J. Hill, K. Komschlies, J. Tomaszewski, et al. 2003. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV- infected nonhuman primates. Blood 101: 2294-2299.
89. Nugeyre, M. T., V. Monceaux, S. Beq, M. C. Cumont, R. Ho Tsong Fang, L. Chene, M. Morre, F. Barre-Sinoussi, B. Hurtrel, and N. Israel. 2003. IL-7 stimulates T cell renewal without increasing viral replication in simian immunodeficiency virus-infected macaques. J. Immunol. 171: 4447-4453.
90. + T-regulatory cells. J. Immunother. 29: 313-319.